Use of health-related quality of life information in managed care formulary decision-making

Wu, Wenchen; Sause, Robert B.; Zacker, Christopher

doi:10.1016/j.sapharm.2005.09.004

Cited by 3 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Using patient-reported data during consultations can help healthcare professionals to identify the need to make changes to the treatment plan or medication, refer patients to other professionals, order further tests or take actions to improve patients' self-efficacy to handle their disease [39][40][41][42][43]. It has been shown that if doctors have the results of the measurement available during the patient encounter, it allows the most important current health issues for the patient to be directly addressed [44][45][46][47][48][49][50][51][52][53][54]. Patients are also reported to feel more empowered, maybe because the use of this type of measurement encourages them to reflect upon their situation, thereby increasing self-awareness, and also because it indicates that the healthcare professionals will be interested in listening to their problems [55].…”

Section: Usefulness Of Proms In Health Carementioning

confidence: 99%

Patient‐reported outcomes in the Swedish National Quality Registers

2015

View full text Add to dashboard Cite

Patient-reported outcomes (PROs) are important in the healthcare system to gain understanding of patients' views on the effects of a treatment. There is an abundance of available patient-reported outcome measures (PROMs), both disease specific and generic. In the Swedish healthcare system, the national quality registers are obliged to incorporate PROs for certification at a high level. A review of the latest annual applications for funding (n = 108) shows that at present, 93 national quality registers include some form of PROM or patient-reported experience measure (PREM). Half of the registers include some type of generic measure, more than half include disease/symptom-specific measures, and around 40% include PREMs. Several different measures and combinations of measures are used, the most common of which are the EQ-5D, followed by the SF-36/RAND-36. About one-fifth of the registers report examples of how patient-reported data are used for local quality improvement. These examples include enhancing shared decision-making in clinical encounters (most common), as a basis for care plans, clinical decision aids and treatment guidelines, to improve the precision of indications for surgery (patient and healthcare professional assessments may differ), to monitor complications after the patient has left hospital and to improve patient information. In addition, funding applications reveal that most registers plan to extend their array of PROMs and PREMs in future, and to increase their use of patient-reported data as a basis for quality improvement.

show abstract

Section: Usefulness Of Proms In Health Carementioning

confidence: 99%

Patient‐reported outcomes in the Swedish National Quality Registers

2015

View full text Add to dashboard Cite

show abstract

“…However, other participants pointed out that major payers (e.g., WellPoint), and large managed care organizations (e.g., Kaiser‐Permanente) cover a “community” of individuals that is the size of many European countries. Some of these organizations had already considered the impacts of therapy on quality of life in their decision‐making processes [5,6]. It was also noted that, although there has been a resistance to considering cost or cost‐effectiveness in the past, the mood in the United States was changing, given the growing unaffordability of health care in both public and private sectors.…”

Section: Discussion: Identifying Ways Forwardmentioning

confidence: 99%

Toward a Consensus on the QALY

et al. 2009

View full text Add to dashboard Cite

“…However, our response rate was higher than or equal to the response rate in other surveys of managed care stakeholders and biomedical manufacturers (7.7%-34.7%). [23][24][25][26] Third, because of constraints on the duration of the CPE presentation, we limited the policy choices to 8 and discussed in detail only 3 of the those. Future research should consider a survey of the full list of options.…”

Section: Alternative Policy Options and Potential Barriers To Adoptionmentioning

confidence: 99%

Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs

Yeung

Suh

Basu

et al. 2017

JMCP

View full text Add to dashboard Cite

No funding was provided for this research. Carlson reports consulting fees from Genentech, Pfizer, and Seattle Genetics. The other authors have nothing to disclose. Study concept and design were contributed by Yeung, Garrison, and Carlson. Yeung collected the data, which were interpreted by Yeung and Basu. The manuscript was written by Yeung, Suh, and Bansal and revised by Yeung. A portion of this research was presented at the Academy of Managed Care & Specialty Pharmacy Annual Meeting as a continuing education session entitled "Paying for Cures: How Can We Afford It?" on April 20, 2016, in San Francisco, California.

show abstract

Use of health-related quality of life information in managed care formulary decision-making

Cited by 3 publications

References 18 publications

Patient‐reported outcomes in the Swedish National Quality Registers

Patient‐reported outcomes in the Swedish National Quality Registers

Toward a Consensus on the QALY

Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs

Contact Info

Product

Resources

About